Article
05 Oct 2026
FDA Medical Devices: Important Regulatory Considerations For Companies Seeking To Enter The U.S. Market
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
20 Apr 2026
FDA Clarifies Policies For Pharmacy Compounders Of GLP-1 Products
Article
16 Apr 2026
FDA To Consider Lifting Restrictions On Numerous Compounded Peptides
Article
17 Mar 2026
GLP‑1 Compliance: FDA Targets Telehealth Marketing In 30 New Warning Letters
Article
29 Jan 2026
Digital Health Policy: FDA Relaxes Restrictions Over Wearables And AI Decision Making Tools In Two New 2026 Guidances
Article
16 Sep 2025
FDA On The Offense! Targeting Pharmaceutical Company Drug Advertising In Wave Of Enforcement Actions
Article
29 Jul 2025
GLP-1 Receptor Agonists: Clinical Trial Considerations
Article
05 Apr 2025
Texas Court Vacates FDA's Laboratory Developed Test (LDT) Final Rule
Article
17 Dec 2024
Antibody Drug Conjugates Keep Growing: What You Need To Know
Article
03 Dec 2024
GLP-1 Drugs: Brand Companies Push FDA To Limit Compounding
Article
08 Nov 2024
Cancer Drugs: Clinical Trial Issues For Antibody Drug Conjugates (ADCs)/Antibody Therapeutics
Article
16 Oct 2024
Medicare Coverage: CMS Finalizes New Pathway For Breakthrough Devices
Article
23 May 2024
LDTs: FDA Rolls Out A Phased Implementation For New Regulatory Requirements
Article
09 May 2024
2024 Health Care & Life Sciences Top Trends - Driving Tomorrow's Advances In The Health Care And Life Sciences Ecosystems
Article
19 Mar 2024
Clinical Trials: FDA Issues Finalized Charging Guidance For Investigational Drug Use
Article
06 Mar 2024
OIG Opines On Subsidizing Medicare Cost-Sharing For Clinical Trials
Article
13 Dec 2023
Decentralized Clinical Trials: Diversity In Clinical Trials
Article
11 Oct 2023
FDA Laboratory Developed Test Oversight: What Stakeholders Need To Know About Proposed Overhaul
Article
11 Sep 2023
Clinical Trials: Consent Process Clarified In New FDA Final Guidance
Article
28 Jun 2023
Decentralized Clinical Trials Blog Series